RAMM Pharma Corp. (CSE:RAMM)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Mar 20, 2026

RAMM Pharma Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
-8.91-16.5-7.72-20.96-7.11
Depreciation & Amortization
0.731.211.3410.72
Other Amortization
00-0.020.02
Loss (Gain) From Sale of Assets
-0.77----0.03
Asset Writedown & Restructuring Costs
4.777.561.0713.18-
Loss (Gain) From Sale of Investments
---0.23-0.27
Loss (Gain) on Equity Investments
----0.71
Stock-Based Compensation
-0.170.010.380.7
Provision & Write-off of Bad Debts
0.01-0.06-0.010.070.1
Other Operating Activities
0.442.161.340.090.34
Change in Accounts Receivable
1.080.40.511.51-0.22
Change in Inventory
1.020.58-0.33-0.090.51
Change in Accounts Payable
0.570.49-0.54-1.340.69
Change in Income Taxes
-00--00
Operating Cash Flow
-1.06-4-4.34-5.91-3.83
Capital Expenditures
--0.05-0.06-0.17-0.43
Sale of Property, Plant & Equipment
1.22-0.150.040.03
Cash Acquisitions
----1.113.31
Investment in Securities
-----10
Other Investing Activities
--0.040.090.26
Investing Cash Flow
1.22-0.050.13-1.15-6.83
Long-Term Debt Repaid
-0.15-0.26-0.29-0.13-0.08
Net Debt Issued (Repaid)
-0.15-0.26-0.29-0.13-0.08
Repurchase of Common Stock
---0.17-0.22-0.09
Other Financing Activities
-0.01----
Financing Cash Flow
-0.15-0.26-0.46-0.35-0.18
Foreign Exchange Rate Adjustments
-0.0100.010.04-0.01
Net Cash Flow
-0.01-4.3-4.66-7.38-10.85
Free Cash Flow
-1.06-4.05-4.4-6.08-4.26
Free Cash Flow Margin
-31.54%-93.17%-86.87%-156.02%-103.52%
Free Cash Flow Per Share
-0.01-0.03-0.04-0.05-0.04
Cash Interest Paid
0.250.04---
Cash Income Tax Paid
0.020.01---
Levered Free Cash Flow
1.03-2.86-2.31-3.79-5.03
Unlevered Free Cash Flow
1.18-2.84-2.28-3.79-5.02
Change in Working Capital
2.671.47-0.370.080.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.